Skip to main content
UTMD logo
UTMD
(NASDAQ)
Utah Medical Products, Inc.
$63.12-- (--)
Loading... - Market loading

Utah Medical Products (UTMD) Stock Price & Financial Analysis

Utah Medical Products Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$62.02 - $64.50
52-Week High$68.71
52-Week Low$51.26
Open$62.02
Volume9.84K
Average Volume (3M)9.84K
Market Cap204.51M
Shares Outstanding3.24M
P/E Ratio (TTM)18.05
Forward P/E21.90
Price to Sales (P/S)5.29
Price to Book (P/B)1.71
EV/EBITDA7.69
Revenue (TTM)38.52M
Net Income (TTM)11.29M
Free Cash Flow (TTM)10.95M
EPS (TTM)$3.53
Profit Margin29.30%
Operating Margin30.42%
Return on Equity (ROE)9.46%
Debt to Equity0.00
50-Day MA$63.96
200-Day MA$59.78
52-Week Change12.27%
Annual Dividend$1.23
Dividend Yield1.96%
Payout Ratio34.86%
Last Dividend Ex-DateMar 17, 2026

Frequently Asked Questions About Utah Medical Products

What is the current stock price for UTMD?

As of the latest trading session, UTMD stock trades at $63.12. The 52-week range is $51.26–$68.71, with a day range of $62.02–$64.50.

What is the P/E ratio for UTMD?

Utah Medical Products's trailing P/E ratio is 18.1, meaning investors pay $18.1 for every $1 of annual earnings. The forward P/E is 21.9, reflecting analyst expectations for future earnings. Utah Medical Products operates in the Healthcare sector.

Does UTMD pay dividends?

Yes, Utah Medical Products pays a 1.96% annual dividend yield ($1.23 per share). The payout ratio is 34.9%. The last ex-dividend date was 2026-03-17.

What do analysts recommend for UTMD?

Analyst ratings and recommendations for UTMD are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of UTMD?

Utah Medical Products's market capitalization is $204.5M, classifying it as a micro-cap company. Utah Medical Products operates in the Healthcare sector within the Medical Instruments & Supplies industry.